Multi-Omics Reveals Mechanisms of Partial Modulation of COVID-19 Dysregulation by Glucocorticoid Treatment
Treatments for COVID-19 infections have improved dramatically since the beginning of the pandemic, and glucocorticoids have been a key tool in improving mortality rates. The UK’s National Institute for Health and Care Excellence guidance is for treatment to be targeted only at those requiring oxygen...
Main Authors: | Matt Spick, Amy Campbell, Ivona Baricevic-Jones, Johanna von Gerichten, Holly-May Lewis, Cecile F. Frampas, Katie Longman, Alexander Stewart, Deborah Dunn-Walters, Debra J. Skene, Nophar Geifman, Anthony D. Whetton, Melanie J. Bailey |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/20/12079 |
Similar Items
-
Network Pharmacology Based Research on the Combination Mechanism Between Escin and Low Dose Glucocorticoids in Anti-rheumatoid Arthritis
by: Leiming Zhang, et al.
Published: (2019-03-01) -
Meta-Analysis of COVID-19 Metabolomics Identifies Variations in Robustness of Biomarkers
by: Anthony Onoja, et al.
Published: (2023-09-01) -
Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion
by: von Mässenhausen, Anne, et al.
Published: (2023) -
Context Modulates Outcome of Perinatal Glucocorticoid Action in the Brain
by: Edo Ronald ede Kloet, et al.
Published: (2014-07-01) -
Ciclesonide activates glucocorticoid signaling in neonatal rat lung but does not trigger adverse effects in the cortex and cerebellum
by: Juliann D. Jaumotte, et al.
Published: (2021-08-01)